Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies DOI Creative Commons

Laurence Haddadin,

Xueqin Sun

Cells, Год журнала: 2025, Номер 14(7), С. 538 - 538

Опубликована: Апрель 3, 2025

Stem cells have emerged as a pivotal area of research in the field oncology, offering new insights into mechanisms cancer initiation, progression, and resistance to therapy. This review provides comprehensive overview role stem cancer, focusing on (CSCs), their characteristics, implications for We discuss origin identification CSCs, tumorigenesis, metastasis, drug resistance, potential therapeutic strategies targeting CSCs. Additionally, we explore use normal therapy, tissue regeneration delivery vehicles anticancer agents. Finally, highlight challenges future directions cell cancer.

Язык: Английский

Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases DOI Creative Commons
Adriana Jiménez, Enrique Estudillo, Mara A. Guzmán‐Ruiz

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 281 - 281

Опубликована: Фев. 20, 2025

The blood–brain barrier (BBB) is a critical structure that maintains brain homeostasis by selectively regulating nutrient influx and waste efflux. Not surprisingly, it often compromised in neurodegenerative diseases. In addition to its involvement these pathologies, the BBB also represents significant challenge for drug delivery into central nervous system. Nanoparticles (NPs) have been widely explored as carriers capable of overcoming this effectively transporting therapies brain. However, their potential directly address ameliorate dysfunction has received limited attention. review, we examine how NPs enhance across treat diseases explore emerging strategies restore integrity vital structure.

Язык: Английский

Процитировано

1

Advances in neural stem cells in aging and age-related neurodegenerative diseases DOI Open Access
Rujia Zhong, Wenhao Huang, Chao Chen

и другие.

Ageing and Neurodegenerative Diseases, Год журнала: 2025, Номер 5(1)

Опубликована: Янв. 26, 2025

With aging, neural stem cells (NSCs) undergo age-related changes, including metabolic abnormalities, disrupted protein homeostasis, mitochondrial dysfunction, reduced genetic stability, and more notably, a diminished capacity for proliferation differentiation. These changes may contribute to the development of neurodegenerative diseases such as Alzheimer’s disease (AD) Parkinson’s (PD). In these conditions, disease-specific pathological interact with alterations NSCs, resulting in impairment neurogenesis, which further leads cognitive, mood, motor decline. Based on potential therapeutics targeting neurogenesis cell-based therapies restore functions NSCs replace degenerated neurons, aiming ameliorate functional decline diseases. While therapies, cell transplantation secretome therapy, show great treatment diseases, challenges tumorigenesis, immune rejection, extraction or storage need be addressed. A better understanding age- disease-related underlying mechanism driving benefits drawbacks therapeutic approaches provide insights novel disease-modifying interventions future

Язык: Английский

Процитировано

0

The Exciting Frontier of Neuroplasticity: Innovations in Brain Health and Recovery DOI Open Access
Ramendra N. Saha

Journal of Behavioral and Brain Science, Год журнала: 2025, Номер 15(03), С. 47 - 80

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies DOI Creative Commons

Laurence Haddadin,

Xueqin Sun

Cells, Год журнала: 2025, Номер 14(7), С. 538 - 538

Опубликована: Апрель 3, 2025

Stem cells have emerged as a pivotal area of research in the field oncology, offering new insights into mechanisms cancer initiation, progression, and resistance to therapy. This review provides comprehensive overview role stem cancer, focusing on (CSCs), their characteristics, implications for We discuss origin identification CSCs, tumorigenesis, metastasis, drug resistance, potential therapeutic strategies targeting CSCs. Additionally, we explore use normal therapy, tissue regeneration delivery vehicles anticancer agents. Finally, highlight challenges future directions cell cancer.

Язык: Английский

Процитировано

0